Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data
By Craig J Whittington, T. Kendall, Peter Fonagy, D. Cottrell, A. Cotgrove, E. Boddington. The Lancet, 2004
995 citations recorded by the source corpus.
Subfields: Clinical Psychology, Pharmacology, Psychiatry and Mental health
View Paper: https://www.semanticscholar.org/paper/d4073334a304f865a69e204d8b8c19c3ed4225ad
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pharmacology
Citations in the corpus
- AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. (2009, neutral): “Additional available electronic databases were also added to the question on literature searching (item 3) and I 2 was added to the item on methods used to combine findings (item 9).”
- Epidemiology and Reporting Characteristics of Systematic Reviews (2007, positive): “In an attempt to minimize or avoid recent questionable behaviours such as hiding data [27], it is now becoming widely endorsed by granting agencies, such as the Canadian Institutes of Health Research [1], and editorial groups, such as the International Committee of Medical Journal Editors [28].”
- CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. (2012, positive): “Provoked by recent serious problems of with-holding data [289], there has been a renewed effort to register randomised trials.”
- CONSORT for Reporting Randomized Controlled Trials in Journal and Conference Abstracts: Explanation and Elaboration (2008, neutral): “Due to more recent serious problems of withholding data [69] there has been a renewed effort to register RCTs.”
- Effects of psychotherapy for depression in children and adolescents: a meta-analysis. (2006, neutral): “Taken together, these findings on the magnitude and specificity of effects may help inform the debate over alternatives to antidepressant medication, as discussed in the introduction (see Glass, 2004; Safer, 1997; TADS Team, 2004; Vitiello & Swedo, 2004; Weisz & Jensen, 1999; Whittington et al., 200”
- Guidance for Developers of Health Research Reporting Guidelines (2010, neutral): “The addition of a new trial registration item reflects current journal practice [22] stemming from some researchers hiding results of randomized trials [23].”
- Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines (2015, neutral): “07) in another metaanalysis (Whittington et al., 2004).”